Prof. Giampaolo Tortora is the Director of Medical Oncology and Director of the Comprehensive Cancer Center at the Fondazione Policlinico Gemelli IRCCS in Rome and is a full professor of Medical Oncology and director of the Specialty and Residency School in Medical Oncology at the Medical School of Università Cattolica del Sacro Cuore in Rome. He obtained his MD degree (summa cum laude) with a specialty in Oncology (summa cum Laude) and Ph.D. in Molecular Biology and Pathology at the University of Napoli “Federico II”, undertook a postdoctoral fellowship at the National Cancer Institute, Bethesda, MD, USA, and visited the NCI in Bethesda and the MD Anderson Cancer Center in Houston. Prof. Tortora's group (including Prof. Ciardiello) contributed to the discovery of gefitinib and cetuximab; vandetanib (in collaboration with Prof. Santoro); and IMO-2125. Within the ICGC, he participated in the discovery and definition of the subgrouping of pancreatic cancer. The results of his studies are reported in over 300 publications in highly rated journals with a total IF over 2200 and an H-Index of 80. He has received several national and international awards, like the Venosta Prize from FIRC. He is a member of held positions in the Scientific and Steering Committee of the ICGC, the Educational Committee of ESMO as Chairman of Translational Research and Personalized Medicine, the Scientific Committee of the AIRC, and the Scientific Committee of the Cancer Institute in Candiolo-Turin.